Amaryl (AM-a-ril, glimepiride), a new sulfonylurea for diabetes
March 2002
Aventis is now marketing Amaryl (AM-a-ril, glimepiride), a new sulfonylurea for diabetes.
It will be used alone or combined with metformin or insulin.
Amaryl works as well as glyburide and gliclazide...and appears to have a lower risk of severe hypoglycemia.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote